Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Collaborative Research and Development Grants

University of British Columbia

$11,575.00

Sensitive and reproducible techniques for spinal cord morphometry on magnetic resonance images with application to multiple sclerosis

FY 2009-10

Summary
Multiple sclerosis (MS) attacks the brain and spinal cord, which can lead to severe disability. Magnetic resonance imaging (MRI) is a highly sensitive tool for observing MS damage in vivo, and is therefore used in the majority of clinical trials evaluating the efficacy of new MS therapies. To understand the complex pathology of MS, the disease-induced changes in both the brain and the spinal cord must be studied and precisely measured where possible. However, while accurate image analysis algorithms for measuring structural changes in the brain are commonly used in MS studies, and the morphometry of specific brain structures remains a very active area of research, the development of algorithms for spinal cord analysis seems to be lagging. The main objective of the proposed project is to improve the sensitivity and reproducibility of spinal cord morphometry on MRI for studying MS. We will design and implement new software methods to address a number of technical issues that we have identified. Pilot data will be collected on healthy volunteers for initial development of the new algorithms, with subsequent validation performed on real clinical data from the MS/MRI Research Group, an interdisciplinary group at the University of British Columbia with extensive experience in the application of neuroimaging biomarkers in MS clinical trials. The primary mandate of the MS/MRI Research Group is to develop better trial methodologies to improve the lives of patients with neurological diseases. MS costs the Canadian economy over $1 billion dollars per year in prescription medications, medical services, and lost earnings. We believe that increasing the sensitivity of spinal cord MRI biomarkers would have a strong impact on the cost-effectiveness of developing new MS drugs, which would directly benefit the pharmaceutical industry and Canadian health care system. By making the drug development process more efficient, better drugs can get to market faster, and the burden of MS on Canadian patients and the economy can be reduced.
Program
Collaborative Research and Development Grants
Location
British Columbia, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
385332-2009
Name nom
Tam, Roger
Department département
Radiology
Organization id
2
Institution établissement
University of British Columbia
Province en
British Columbia
Province fr
Colombie-Britannique
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2009
Competition year année de concours
2009
Award amount
11575
Program id
CRDPJ
Program nane en
Collaborative Research and Development Grants
Program name fr
Subventions de recherche et développement coopérative
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
96
Committee name en
RPP Internal Decision Cttee
Committee name fr
Cté de décision interne - PPR
Area of application code
1101
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Human health (including medically-related psychological research)
Area of application fr
Santé publique (y compris recherche psychologique liée à la médecine)
Research subject code
1900
Research subject group en
Biomedical engineering
Research subject group fr
Génie biomédical
Research subject en
Biomedical engineering
Research subject fr
Génie biomédical
Partie
1
Nb partie
2
Application title
Sensitive and reproducible techniques for spinal cord morphometry on magnetic resonance images with application to multiple sclerosis
Keyword
NA
Application summary
Multiple sclerosis (MS) attacks the brain and spinal cord, which can lead to severe disability. Magnetic resonance imaging (MRI) is a highly sensitive tool for observing MS damage in vivo, and is therefore used in the majority of clinical trials evaluating the efficacy of new MS therapies. To understand the complex pathology of MS, the disease-induced changes in both the brain and the spinal cord must be studied and precisely measured where possible. However, while accurate image analysis algorithms for measuring structural changes in the brain are commonly used in MS studies, and the morphometry of specific brain structures remains a very active area of research, the development of algorithms for spinal cord analysis seems to be lagging. The main objective of the proposed project is to improve the sensitivity and reproducibility of spinal cord morphometry on MRI for studying MS. We will design and implement new software methods to address a number of technical issues that we have identified. Pilot data will be collected on healthy volunteers for initial development of the new algorithms, with subsequent validation performed on real clinical data from the MS/MRI Research Group, an interdisciplinary group at the University of British Columbia with extensive experience in the application of neuroimaging biomarkers in MS clinical trials. The primary mandate of the MS/MRI Research Group is to develop better trial methodologies to improve the lives of patients with neurological diseases. MS costs the Canadian economy over $1 billion dollars per year in prescription medications, medical services, and lost earnings. We believe that increasing the sensitivity of spinal cord MRI biomarkers would have a strong impact on the cost-effectiveness of developing new MS drugs, which would directly benefit the pharmaceutical industry and Canadian health care system. By making the drug development process more efficient, better drugs can get to market faster, and the burden of MS on Canadian patients and the economy can be reduced.
University of British Columbia - $11,575 Grant (2009-… | Canada Spends